Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-04-09

Clinical Trial Update: Ramelteon for Complex Insomnia in Veterans With PTSD [Phase 4]

View source ↗

Summary

Phase 4 trial of ramelteon for complex insomnia in veterans with PTSD was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Insomnia | Phase 4 | Status: WITHDRAWN